XBiotech Candidate True Human™ COVID-19 Therapy Found to Target Highly Infectious Emerging Strain

NEXT STORY
Global Galacto-Oligosaccharides Market to Grow with a CAGR of 10.15% Throughout 2021-2028 Owing to Rising Demand for Microbiota-Targeted Therapies and Precision Nutrition Products; Market to Cross USD 1,120 Million in 2028
PREV STORY
electroCore, Inc. Announces Scottish Health Technology Group Recommendation For Use of gammaCore™ in NHS Scotland Cluster Headache Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

China National Medical Products Administration grants approval of Roche’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer

author_avatar
NASDAQ Market News

Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant in Patients with Cushing’s Syndrome of Adrenal Origin

author_avatar
NASDAQ Market News

Roche to present new data in multiple sclerosis and neuromyelitis optica spectrum disorder at MSVirtual2020

author_avatar
NASDAQ Market News